Proxy Biomedical

Galway, Ireland Founded: 2002 • Age: 24 yrs Acquired By Integer
Biomaterial-focused medical implant products are designed, developed, and manufactured.

About Proxy Biomedical

Proxy Biomedical is a company based in Galway (Ireland) founded in 2002 was acquired by Integer in April 2022. Proxy Biomedical offers products and services including Medical Textiles, Implant Coating, Nitinol Braiding, PTFE Implant Covering, and Absorbable Implants.

Key Metrics
  • Latest Funding Round
    $289.47K (USD), Grant

    Feb 2016

  • Investors
    Integer

    & 1 more

  • Acquired by
    Integer

    (Apr 2022)

Products & Services of Proxy Biomedical

Proxy Biomedical offers a comprehensive portfolio of products and services, including Medical Textiles, Implant Coating, Nitinol Braiding, PTFE Implant Covering, and Absorbable Implants.

Medical Textiles
Implantable Materials

Custom fabrics for medical implants and devices.

Implant Coating
Surface Technologies

Coatings to enhance implant performance and durability.

Nitinol Braiding
Biomaterial Processing

Braiding services for flexible medical device components.

PTFE Implant Covering
Material Encapsulation

Coverings to protect and improve implant functionality.

Absorbable Implants
Biodegradable Devices

Development of materials that dissolve in the body over time.

Apps and channels of Proxy Biomedical

its YouTube channel Aran Biomedical has 75 subscribers and 13 videos.

Aran Biomedical
YouTube 75 subscribers 13 videos Science & Technology
Open channel

Videos from Proxy Biomedical

The most watched videos on Proxy Biomedical's YouTube channel, Aran Biomedical (75 subscribers). Click a video to play it here.

Aran Biomedical Corporate Video
5.8K views
Implant Development Solutions
4.2K views
Advanced Nitinol Braiding - Aran Biomedical
2.8K views
Aran Biomedical - High Precision Implant Coating Solutions
1.1K views

More on Aran Biomedical.

Funding Insights of Proxy Biomedical

  • Total Rounds 1
  • Last Round Grant β€” $289,466
  • First Round $289,466

    (Feb 2016)

  • Investors Count 1

All 1 funding rounds of Proxy Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2016$289,466Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Proxy Biomedical

Proxy Biomedical has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Integer and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Medical device components are developed and manufactured for healthcare markets.
1970integer.netFrisco, United States
Premium access

Investor details for Proxy Biomedical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Proxy Biomedical

3 dated milestones of Proxy Biomedical across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Proxy Biomedical is founded.
  2. Funding First funding round of $289K.
  3. Exit Acquired by Integer.

Similar companies to Proxy Biomedical

10 companies that operate in the same segment as Proxy Biomedical (Diversified Medical Devices), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United States–USD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United States–USD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United States–USD 94.18 B139,800
Diagnostic and surgical products for women's healthcare are provided.
1985Marlborough, Massachusetts, United States–USD 4.1 B7,060
Developer of drug candidates for the treatment of rare CNS disorders
1971Boston, Massachusetts, United StatesUSD 105.8 M–487
Surgical instruments are manufactured for multiple therapeutic areas.
1987Utica, New York, United States–USD 1.37 B3,900
A wide range of medical devices is developed by HOYA.
1941Tokyo, Tokyo, Japan–USD 5.94 B37,910
Medical devices for cardiac and neuromodulation therapies are manufactured globally.
1976Saint Paul, Minnesota, United States–––
Complex healthcare challenges are addressed through technology solutions by Commure.
2016San Francisco, California, United StatesUSD 823.3 M–316
Provider of medical devices for emergency medicine and various health conditions
1943Wayne, United States–USD 1.99 B14,100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Proxy Biomedical

Proxy Biomedical was founded in 2002 and raised its 1st funding round 14 years after it was founded.

Proxy Biomedical is headquartered in Galway, Ireland.

Proxy Biomedical was founded in 2002 in Galway, Ireland, where operations center on the design, development, and manufacture of medical implant products utilizing biomaterials. Coverage extends to sectors including general surgery, orthopaedics, wound care, cardiovascular applications, and drug delivery. Contractual support is provided to medical device firms for their product development objectives.

Proxy Biomedical offers Medical Textiles, Implant Coating, Nitinol Braiding, PTFE Implant Covering, and Absorbable Implants.

Proxy Biomedical has 2 investors. Key investors include Integer, and European Union.

Proxy Biomedical operates through Aran Biomedical Teoranta.

Yes. Proxy Biomedical was acquired by Integer in April 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available